Tests a decision aid for heart protection in cancer survivors
Tests a decision aid for heart care in adults with heart disease risk.
Key facts
- Who runs it
- Medical College of Wisconsin
- Where
- Milwaukee, United StatesSee the site
- Trial code
- Registry title
- PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
- Status
- Not yet recruiting
- People taking part
- 60 people, planned
- Starts
- Dec 2027
- Expected to end
- Dec 2029
- Type of study
- Observational, 2 groups
- Treatments tested
- Clinical Decision Aid
- Standard Care
- Record updated
- 3 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have had cancer, have not yet seen a cardiologist about heart risk since the diagnosis, and are at medium to very high risk of heart disease.
- Age
- 18 years or older.
- Sex
- All sexes can join.
- Disease stage
- A history of cancer, with intermediate, high, or very high risk of cardiovascular disease.
- Earlier treatment
- Must not have seen a cardiologist to assess cardiovascular risk since the cancer diagnosis.
Main reasons for not taking part
- Under 18 years old
- No personal history of cancer
- Heart muscle disease (cardiomyopathy) diagnosed after the cancer diagnosis
- Documented cognitive impairment
- Unable or unwilling to sign the informed consent form
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Patients ≥18 years with a history of cancer
- Have not previously visited a cardiologist to assess cardiovascular risk after cancer diagnosis
- Clinically at intermediate, high, or very high risk for cardiovascular diseases determined based on imprecise clinical risk models, such as those used for cardiac dysfunction
- Ability to understand a written informed consent form, and willing to sign it prior to study registration
Who cannot take part
- Without a personal history of cancer
- Existing cardiomyopathy diagnosed after cancer diagnosis
- Documented cognitive impairment
- Patient <18 years
- Patient or patient representative who is unable and unwilling to sign the informed consent form
Where in United States
- Froedtert & the Medical College of WisconsinMilwaukee, United StatesContact: Yee Chung Chen, MD (principal investigator)Not yet recruiting
About the trial
What the trial wants to find out
This is a single-center, double-arm, open-label, randomized feasibility study that will determine whether a novel clinical decision aid accessed via the electronic health record will be acceptable to both cancer survivors and their cardiologists, will favorably impact appropriate medication use and cardiac imaging surveillance, and will improve clinician and patient decision-making, perception, and behavior towards cardioprotective medication usage and cardiovascular disease imaging utilization.
The 2 groups in the trial
- Clinical Decision Aid Group
In this group, physicians will use standard care plus the clinical decision aid.
Treatment: Clinical Decision Aid
- Control Group
In this group, physicians will use standard care only.
Treatment: Standard Care
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
- Plain-language title
- Tests a decision aid for heart protection in cancer survivorsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- PrevCardioOncAI: Machine Learning Algorithms for Predicting Cardiovascular Disease in Cancer Survivors.Journal of the American Heart Association, 2025
- Record updated
- 3 November 2026